Mycobacterium tuberculosis (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mycobacterium tuberculosis" in Swedish language version.

refsWebsite

Global rank Swedish rank

31doi.org

2^nd place

14^th place

16nih.gov

4^th place

17^th place

2folkhalsomyndigheten.se

low place

339^th place

2nature.com

234^th place

206^th place

1ki.se

low place

149^th place

1microbiologyresearch.org

low place

9,677^th place

1sciencedirect.com

149^th place

211^th place

1futuremedicine.com

low place

1scielo.br

1,606^th place

2,790^th place

1lakareutangranser.se

low place

1sva.se

low place

793^rd place

11177.se

low place

124^th place

1lnu.se

low place

1,512^th place

1177.se

1177 vårdguiden (2019). ”Tuberkulos – tbc”. 1177 - vårdguiden. https://www.1177.se/Dalarna/sjukdomar--besvar/infektioner/infektioner-i-lungorna/tuberkulos--tbc/. Läst 22 april 2019.

doi.org

dx.doi.org

Smith, I. (2003). ”Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence”. American Society for Microbiology Journals 16(3): sid. 463–496. doi:10.1128/CMR.16.3.463-496.2003.
Bañuls A., Sanou A., Nguyen T. V. A., Godreuil S. (2015). ”Mycobacterium tuberculosis: ecology and evolution of a human bacterium”. Journal of Medical Microbiology, 64(11): sid. 1261-1269. doi:10.1099/jmm.0.000171.
Brites D. & Gagneux S. (2015). ”Co-evolution of Mycobacterium tuberculosis and Homo sapiens”. Immunological Reviews, 264(1): sid. 6-24. doi:10.1111/imr.12264.
Glickman, M. S. & Jacobs Jr, W. R. (2001). ”Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline”. Cell 104: sid. 477-485. doi:10.1016/S0092-8674(01)00236-7.
Dunn, J,J.; Starke, J. R.; Revella, P. A. (2016). ”Laboratory Diagnosis of Mycobacterium tuberculosis Infection and Disease in Children”. Journal of Clinical Microbiology 54(6): sid. 1434-1441. doi:10.1128/JCM.03043-15.
Camus, J-C; Pryor, M. J.; Médigue, C; Cole, S. T. (2002). ”Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv”. Microbiology Society 148: sid. 2967-2973. doi:10.1099/00221287-148-10-2967. https://mic.microbiologyresearch.org/content/journal/micro/10.1099/00221287-148-10-2967#R6.
Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry III, C. E.; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M.-A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead S. & Barrell, B. G. (1998). ”Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence”. Nature 393 (6685): sid. 537–544. doi:10.1038/31159. https://www.nature.com/articles/31159.
Peddireddy, V.; Doddam, S. N.; Ahmed, N. (2017). ”Mycobacterial Dormancy Systems and Host Responses in Tuberculosis”. Frontiers in Immunology 8. doi:10.3389/fimmu.2017.00084. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309233/.
Elkington, P. T. (2013). ”Tuberculosis, time for a new perspective?”. Journal of Infection 66: sid. 299-302. doi:10.1016/j.jinf.2013.02.002. https://www.sciencedirect.com/science/article/abs/pii/S0163445313000261.
Cao, J.; Dang, G.; Li, H.; Li, T.; Yue, Z.; Li, N. (2015). ”Identification and Characterization of Lipase Activity and Immunogenicity of LipL from Mycobacterium tuberculosis”. PLoS ONE 10 (9). doi:10.1371/journal.pone.0138151. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580317/.
Huang, L.; Nazarova, E. V.; Russell, D. G. (2019). ”Mycobacterium tuberculosis: Bacterial fitness within the host macrophage”. Microbiology spectrum 7 (2). doi:10.1128/microbiolspec.BAI-0001-2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459685/.
Höner zu Bentrup, K.; Russell, D. G. (2001). ”Mycobacterial persistence: adaptation to a changing environment”. Trends in Microbiology 9 (12): sid. 597–605. doi:10.1016/S0966-842X(01)02238-7. https://www.ncbi.nlm.nih.gov/pubmed/11728873/.
Lin, P. L.; Ford, C. B.; Coleman, M. T.; Myers, A. J.; Gawande, R.; Ioerger, T. (2014). ”Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing”. Nature medicine 20 (1): sid. 75–79. doi:10.1038/nm.3412. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947310/.
VanderVen, B. C.; Huang, L.; Rohde, K. H.; Russell, D. G. (2016). ”The minimal unit of infection: M. tuberculosis in the macrophage”. Microbiology spectrum 4 (6). doi:10.1128/microbiolspec.TBTB2-0025-2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245711/.
Namasivayam, S.; Sher, A.; Glickman, M. S.; Wipperman, M. F. (2018). ”The Microbiome and Tuberculosis: Early Evidence for Cross Talk”. mBio 9 (5). doi:10.1128/mBio.01420-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143735/.
Eoh, H.; Wang, Z.; Layre, E.; Rath, P.; Morris, R.; Moody, D. B. (2017). ”Metabolic anticipation in Mycobacterium tuberculosis”. Nature microbiology 2 (17084). doi:10.1038/nmicrobiol.2017.84. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540153/.
Taneja, N. K.; Ahmed, N.; Dhingra, S.; Mittal, A.; Naresh, M.; Tyagi, J. (2010). ”Mycobacterium tuberculosis transcriptional adaptation, growth arrest and dormancy phenotype development is triggered by vitamin C”. PLoS ONE 5 (5). doi:10.1371/journal.pone.0010860. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877710/pdf/pone.0010860.pdf.
Cook, G. M.; Berney, M.; Gebhard, S.; Heinemann, M.; Cox, R. A.; Danilchanka, O. (2009). ”Physiology of Mycobacteria”. Advances in microbial physiology 55: sid. 81–319. doi:10.1016/S0065-2911(09)05502-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728839/.
Vincent, A. T.; Nyongesa, S.; Morneau, I.; Reed, M. B.; Tocheva, E. I.; Veyrier, F. J. (2018). ”The Mycobacterial Cell Envelope: A Relict From the Past or the Result of Recent Evolution?”. Frontiers in Microbiology 9 (2341). doi:10.3389/fmicb.2018.02341. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194230/.
Rameshwaram, N. R.; Singh, P.; Ghosh, S.; Mukhopadhyay, S. (2018). ”Lipid metabolism and intracellular bacterial virulence: key to next-generation therapeutics”. Future Microbiology 13 (11): sid. 1301–1328. doi:10.2217/fmb-2018-0013. https://www.futuremedicine.com/doi/full/10.2217/fmb-2018-0013.
Blanc, L.; Gilleron, M.; Prandi, J.; Song, O-R.; Jang, M-S.; Gicquel, Br. (2017). ”Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids”. Proceedings of the National Academy of Sciences of the United States of America 114 (42): sid. 11205–11210. doi:10.1073/pnas.1707840114. https://www.ncbi.nlm.nih.gov/pubmed/28973928.
Aldridge, B. B.; Fernandez-Suarez, M.; Heller, D.; Ambravaneswaran, V.; Irimia, D.; Toner, M. (2012). ”Asymmetry and aging of mycobacterial cells leads to variable growth and antibiotic susceptibility”. Science (New York, N.y.) 335 (6064): sid. 100–104. doi:10.1126/science.1216166. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397429/.
Raman, K.; Rajagopalan, P.; Chandra, N. (2005). ”Flux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs”. PLoS Computational Biology 1 (5). doi:10.1371/journal.pcbi.0010046. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246807/.
Melly, G.; Purdy, G. E. (2019). ”MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis”. Microorganisms 7 (3). doi:10.3390/microorganisms7030070. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463170/.
Niederweis, M.; Danilchanka, O.; Huff, J.; Hoffmann, C.; Engelhardt, H. (2010). ”Mycobacterial outer membranes: in search of proteins”. Trends in microbiology 18 (3): sid. 109–116. doi:10.1016/j.tim.2009.12.005. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931330/.
Bhat, Z. S. Rather, M. A. Maqbool, M. Lah, H. U. Yousuf, S. K. Ahmad, Z. (2017). ”Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis”. Biomedicine & Pharmacotherapy 95: sid. 1520-1534. doi:10.1016/j.biopha.2017.09.036.
Riley, L. W.; Queiroz, A. (2017). ”Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response”. Revista da Sociedade Brasileira de Medicina Tropical 50 (1): sid. 9–18. doi:10.1590/0037-8682-0230-2016. http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0037-86822017000100009&lng=en&nrm=iso&tlng=en.
Lambert, P. A. (2002). Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. "92". Journal of Applied Microbiology. sid. 46-54. doi:10.1046/j.1365-2672.92.5s1.7.x.
Coscolla, M. & Gagneux, S. (2014). ”Consequenses of genomic diversity in Mycobacterium tuberculosis”. Seminars in Immunology, 26(6), sid.431-444. doi:10.1016/j.smim.2014.09.012.
Berry, M. P. R, Graham, M. C, McNab, W. F, Xu, Z, Bloch, S. A. A, Oni, T, Wilkinson A. K, Banchereau, R, Skinner, J, Wilkinson, J. R, Quinn, C, Blankenship, D, Dhawan, R, Cush, J. J, Mejias, A, Ramilo, O, Kon, O. M, Pascual, V, Banchereau, J, Chaussabel, D & O´Garra, A (2010). ”An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis”. Nature 466 (7309): sid. 973-977. doi:https://doi.org/10.1038/nature09247. https://www.nature.com/articles/nature09247?fbclid=IwAR1lMZz37i05a9W61YdpUWU9QtahVDsxrYjTl0ZUJIU6-xMCgdJ4NRnV4T0.
Jiansong, T.; Wing-Cheong, Y.; Zhiwei, C. (2016). ”Mycobacterium tuberculosis infection and vaccine development”. Tuberculosis 98: sid. 30-41. doi:10.1016/j.tube.2016.02.005. https://doi-org.proxy.lnu.se/10.1016/j.tube.2016.02.005.

folkhalsomyndigheten.se

”Folkhälsomyndigheten - Tuberkulos”. https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/sjukdomsstatistik/tuberkulos/. Läst 29 april 2019.
Folkhälsomyndigheten. ”Vaccin mot tuberkulos (TB)”. Folkhälsomyndigheten. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vacciner-a-o/tuberkulos-tb/. Läst 22 april 2019.

futuremedicine.com

Rameshwaram, N. R.; Singh, P.; Ghosh, S.; Mukhopadhyay, S. (2018). ”Lipid metabolism and intracellular bacterial virulence: key to next-generation therapeutics”. Future Microbiology 13 (11): sid. 1301–1328. doi:10.2217/fmb-2018-0013. https://www.futuremedicine.com/doi/full/10.2217/fmb-2018-0013.

ki.se

Hedlund, F. (2018). ”Världens infektionsfiende nummer”. Karolinska Institutet. https://ki.se/forskning/varldens-infektionsfiende-nummer-1. Läst 23 april 2019.

lakareutangranser.se

Läkare utan gränser (2017). ”Tre människor dör i tuberkulos varje minut”. Läkare utan gränser. https://lakareutangranser.se/nyheter/tre-manniskor-dor-i-tuberkulos-varje-minut?fbclid=IwAR1o5olXOIFbIWUwOFG3wpAzkfKjdC8SbIJpV0kjSRzjfqNfJjLoIqd3Xt8. Läst 4 maj 2019.

lnu.se

doi-org.proxy.lnu.se

Jiansong, T.; Wing-Cheong, Y.; Zhiwei, C. (2016). ”Mycobacterium tuberculosis infection and vaccine development”. Tuberculosis 98: sid. 30-41. doi:10.1016/j.tube.2016.02.005. https://doi-org.proxy.lnu.se/10.1016/j.tube.2016.02.005.

microbiologyresearch.org

mic.microbiologyresearch.org

Camus, J-C; Pryor, M. J.; Médigue, C; Cole, S. T. (2002). ”Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv”. Microbiology Society 148: sid. 2967-2973. doi:10.1099/00221287-148-10-2967. https://mic.microbiologyresearch.org/content/journal/micro/10.1099/00221287-148-10-2967#R6.

nature.com

Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry III, C. E.; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M.-A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead S. & Barrell, B. G. (1998). ”Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence”. Nature 393 (6685): sid. 537–544. doi:10.1038/31159. https://www.nature.com/articles/31159.
Berry, M. P. R, Graham, M. C, McNab, W. F, Xu, Z, Bloch, S. A. A, Oni, T, Wilkinson A. K, Banchereau, R, Skinner, J, Wilkinson, J. R, Quinn, C, Blankenship, D, Dhawan, R, Cush, J. J, Mejias, A, Ramilo, O, Kon, O. M, Pascual, V, Banchereau, J, Chaussabel, D & O´Garra, A (2010). ”An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis”. Nature 466 (7309): sid. 973-977. doi:https://doi.org/10.1038/nature09247. https://www.nature.com/articles/nature09247?fbclid=IwAR1lMZz37i05a9W61YdpUWU9QtahVDsxrYjTl0ZUJIU6-xMCgdJ4NRnV4T0.

nih.gov

ncbi.nlm.nih.gov

Peddireddy, V.; Doddam, S. N.; Ahmed, N. (2017). ”Mycobacterial Dormancy Systems and Host Responses in Tuberculosis”. Frontiers in Immunology 8. doi:10.3389/fimmu.2017.00084. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309233/.
Cao, J.; Dang, G.; Li, H.; Li, T.; Yue, Z.; Li, N. (2015). ”Identification and Characterization of Lipase Activity and Immunogenicity of LipL from Mycobacterium tuberculosis”. PLoS ONE 10 (9). doi:10.1371/journal.pone.0138151. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580317/.
Huang, L.; Nazarova, E. V.; Russell, D. G. (2019). ”Mycobacterium tuberculosis: Bacterial fitness within the host macrophage”. Microbiology spectrum 7 (2). doi:10.1128/microbiolspec.BAI-0001-2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459685/.
Höner zu Bentrup, K.; Russell, D. G. (2001). ”Mycobacterial persistence: adaptation to a changing environment”. Trends in Microbiology 9 (12): sid. 597–605. doi:10.1016/S0966-842X(01)02238-7. https://www.ncbi.nlm.nih.gov/pubmed/11728873/.
Lin, P. L.; Ford, C. B.; Coleman, M. T.; Myers, A. J.; Gawande, R.; Ioerger, T. (2014). ”Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing”. Nature medicine 20 (1): sid. 75–79. doi:10.1038/nm.3412. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947310/.
VanderVen, B. C.; Huang, L.; Rohde, K. H.; Russell, D. G. (2016). ”The minimal unit of infection: M. tuberculosis in the macrophage”. Microbiology spectrum 4 (6). doi:10.1128/microbiolspec.TBTB2-0025-2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245711/.
Namasivayam, S.; Sher, A.; Glickman, M. S.; Wipperman, M. F. (2018). ”The Microbiome and Tuberculosis: Early Evidence for Cross Talk”. mBio 9 (5). doi:10.1128/mBio.01420-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143735/.
Eoh, H.; Wang, Z.; Layre, E.; Rath, P.; Morris, R.; Moody, D. B. (2017). ”Metabolic anticipation in Mycobacterium tuberculosis”. Nature microbiology 2 (17084). doi:10.1038/nmicrobiol.2017.84. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540153/.
Taneja, N. K.; Ahmed, N.; Dhingra, S.; Mittal, A.; Naresh, M.; Tyagi, J. (2010). ”Mycobacterium tuberculosis transcriptional adaptation, growth arrest and dormancy phenotype development is triggered by vitamin C”. PLoS ONE 5 (5). doi:10.1371/journal.pone.0010860. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877710/pdf/pone.0010860.pdf.
Cook, G. M.; Berney, M.; Gebhard, S.; Heinemann, M.; Cox, R. A.; Danilchanka, O. (2009). ”Physiology of Mycobacteria”. Advances in microbial physiology 55: sid. 81–319. doi:10.1016/S0065-2911(09)05502-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728839/.
Vincent, A. T.; Nyongesa, S.; Morneau, I.; Reed, M. B.; Tocheva, E. I.; Veyrier, F. J. (2018). ”The Mycobacterial Cell Envelope: A Relict From the Past or the Result of Recent Evolution?”. Frontiers in Microbiology 9 (2341). doi:10.3389/fmicb.2018.02341. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194230/.
Blanc, L.; Gilleron, M.; Prandi, J.; Song, O-R.; Jang, M-S.; Gicquel, Br. (2017). ”Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids”. Proceedings of the National Academy of Sciences of the United States of America 114 (42): sid. 11205–11210. doi:10.1073/pnas.1707840114. https://www.ncbi.nlm.nih.gov/pubmed/28973928.
Aldridge, B. B.; Fernandez-Suarez, M.; Heller, D.; Ambravaneswaran, V.; Irimia, D.; Toner, M. (2012). ”Asymmetry and aging of mycobacterial cells leads to variable growth and antibiotic susceptibility”. Science (New York, N.y.) 335 (6064): sid. 100–104. doi:10.1126/science.1216166. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397429/.
Raman, K.; Rajagopalan, P.; Chandra, N. (2005). ”Flux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs”. PLoS Computational Biology 1 (5). doi:10.1371/journal.pcbi.0010046. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246807/.
Melly, G.; Purdy, G. E. (2019). ”MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis”. Microorganisms 7 (3). doi:10.3390/microorganisms7030070. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463170/.
Niederweis, M.; Danilchanka, O.; Huff, J.; Hoffmann, C.; Engelhardt, H. (2010). ”Mycobacterial outer membranes: in search of proteins”. Trends in microbiology 18 (3): sid. 109–116. doi:10.1016/j.tim.2009.12.005. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931330/.

scielo.br

Riley, L. W.; Queiroz, A. (2017). ”Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response”. Revista da Sociedade Brasileira de Medicina Tropical 50 (1): sid. 9–18. doi:10.1590/0037-8682-0230-2016. http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0037-86822017000100009&lng=en&nrm=iso&tlng=en.

sciencedirect.com

Elkington, P. T. (2013). ”Tuberculosis, time for a new perspective?”. Journal of Infection 66: sid. 299-302. doi:10.1016/j.jinf.2013.02.002. https://www.sciencedirect.com/science/article/abs/pii/S0163445313000261.

sva.se

Statens veterinärmedicinska anstalt (2018). ”Tuberkulos (Mycobacterium tuberculosis, Mycobacterium bovis) hos hund”. Statens veterinärmedicinska anstalt. https://www.sva.se/djurhalsa/hund/infektionssjukdomar-hund/tuberkulos-hund?fbclid=IwAR3L9LBhMEjGyNLp0qw70vHqqNY4r8A6JxZQ77urQ4YfI9Od5ziBD9paijk. Läst 24 april 2019.